Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.10
Bid: 3.00
Ask: 3.20
Change: 0.00 (0.00%)
Spread: 0.20 (6.667%)
Open: 3.10
High: 3.10
Low: 3.10
Prev. Close: 3.10
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: ValiRx receives shareholder request for board change

Fri, 09th Feb 2024 20:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says it has received a requisition notice from a shareholder group proposing certain changes to the board. Seeks legal advice as to the validity of the requisition notice and a further announcement will be made in due course.

----------

The Property Franchise Group PLC - Bournemouth, England-based lettings and estate agency franchising firm - Reports close to 100% shareholder backing for the all-share merger with The Belvoir Group PLC at the General Meeting.

----------

Kin and Carta PLC - London-based business software consultancy - Ahead of the Court Meeting and General Meeting, reiterates unanimous recommendation that scheme shareholders vote in favour of the scheme at the Court Meeting and the special resolution proposed at the General Meeting. This is to facilitate the bid for Kin and Carta by Valtech. Points out that Apax Partners, which had also made a bid for the company, said Friday it would not increasing the terms of its 120 pence per share offer. Valtech's bid is worth 130p per Kin and Carta share. Explains discussions with other parties had not led to a bid for the company, and no talks are currently ongoing.

----------

Catenae Innovation PLC - London-based digital media and technology provider using blockchain technology to support clients with operations and staff management - Says at Annual General Meeting all resolutions were passed including name change to Catenai PLC and the share capital reorganisation. Once the change of name takes effect, the group's ticker for AIM will be CTAI.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
9 Feb 2016 14:17

ValiRx confident in two ongoing clinical trials

(ShareCast News) - ValiRx was confident in the potential of two of its compounds on Tuesday, in its quarterly update on its ongoing clinical trials. The AIM-traded life science firm, with a focus on cancer diagnostics and therapeutics for personalised medicine, said that recent testing had shown VAL

Read more
9 Feb 2016 10:42

WINNERS & LOSERS SUMMARY: Bond Disclosure Sends Legal & General Higher

Read more
9 Feb 2016 09:15

ValiRx Shares Rise After Positive Clinical Trial News For VAL201

Read more
19 Nov 2015 11:40

ValiRx Says VAL201 Dose Escalation Complete, Preparing VAL401 Trials

Read more
5 Nov 2015 10:39

ValiRx Opens US Office In Boston, Massachusetts

Read more
27 Oct 2015 08:41

ValiRx Inks Three-Year Collaboration Deal With Finland's Pharmatest

Read more
1 Oct 2015 06:50

ValiRx Granted New Biomarker Patent In Japan

Read more
17 Sep 2015 11:40

ValiRx Loss Widens Slightly As It Continues Compound Development

Read more
16 Sep 2015 07:27

ValiRx Raises GBP2.5 Million In Subscription, Agrees Equity Swap (ALLISS)

Read more
6 Aug 2015 08:15

ValiRx Strikes Collaboration Deal With University Of Leeds Professor

Read more
21 Jul 2015 11:08

LONDON MARKET MIDDAY: US Stocks Seen Mixed As Tech Giants Report

Read more
21 Jul 2015 08:52

WINNERS & LOSERS SUMMARY: AO World Surges But IG Group Falls

Read more
21 Jul 2015 07:10

ValiRx Provides Positive Update For Ongoing VAL201 Trial

Read more
16 Jul 2015 09:11

ValiRx's ValiSeek Joint Venture Starts Clinical Trial For VAL401

Read more
25 Jun 2015 08:12

ValiRx Says VAL201 Compound Trial To Advance To Dose Escalation

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.